Is Pessimism Warranted for These 3 Most Hated Biotech Stocks?
Short-sellers have dog-piled into these three biotech companies. Is their pessimism warranted or have emotions gotten the better of investors?
3 Reasons to Ignore Analyst Ratings
We can see dozens of analyst upgrades and downgrades issued daily, but they're mostly white noise. Here are three reasons why you shouldn't let these calls alter your long-term investing thesis.